Please ensure Javascript is enabled for purposes of website accessibility

Fitbit Unveils Inexpensive COVID-19 Ventilator

By Donna Fuscaldo – Jun 4, 2020 at 11:31AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The maker of health tracking devices which is being acquired by Alphabet's Google got special approval to make the emergency ventilator.

Fitbit (FIT) announced the launch of a low-cost emergency ventilator for use during the COVID-19 pandemic. 

In a press release, the maker of fitness trackers, which is being acquired by Alphabet's (GOOG 2.70%) (GOOGL 2.62%) Google, said it received an Emergency Use Authorization from the U.S. Food & Drug Administration to develop and bring the ventilator to market. The device is designed to be used only when there isn't a traditional ventilator available.

Fitbit's new Fitbit Flow ventilator.


Dubbed the Fitbit Flow, the tech stock said it's a high-quality, cheap, and easy to use emergency ventilator. Oregon Health & Science University emergency medicine clinicians taking care of pandemic patients consulted with Fitbit during the development of the device.  

"COVID-19 has challenged all of us to push the boundaries of innovation and creativity, and use everything at our disposal to more rapidly develop products that support patients and the healthcare systems caring for them," James Park, co-founder, and CEO of Fitbit said in a press release. "We saw an opportunity to rally our expertise in advanced sensor development, manufacturing, and our global supply chain to address the critical and ongoing need for ventilators and help make a difference in the global fight against this virus."   

While the number of COVID-19 cases has been slowing as social distancing is flattening the curve, hospitals are still in need of ventilators. That's particularly true if there is a surge in cases during the fall or into the winter. Fitbit pointed to the New England Journal of Medicine, which argues that there are still not enough ventilators to care for COVID-19 patients in the coming months. Fitbitiss leveraging its infrastructure and manufacturing capabilities to produce large volumes of these ventilators, which it aims to deploy to healthcare systems in need across the world.

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Donna Fuscaldo has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Alphabet (A shares), Alphabet (C shares), and Fitbit. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Alphabet Inc. Stock Quote
Alphabet Inc.
$100.05 (2.62%) $2.55
Alphabet Inc. Stock Quote
Alphabet Inc.
$100.74 (2.70%) $2.65
Fitbit, Inc. Stock Quote
Fitbit, Inc.

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.